{
    "name": "ranibizumab intravitreal implant",
    "comment": "Rx",
    "other_names": [
        "Susvimo"
    ],
    "classes": [
        "Macular Degeneration Agents",
        "Ophthalmics",
        "VEGF Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/susvimo-ranibizumab-intravitreal-implant-4000254",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies of ranibizumab intravitreal implant in pregnant females",
            "Based on mechanism of action, treatment may pose a risk to human embryofetal development"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Administration of ranibizumab to pregnant monkeys during organogenesis resulted in a low incidence of skeletal abnormalities at intravitreal doses up to 41 times of the human exposure"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for at least 12 months after the last dose "
                ]
            },
            {
                "type": "Infertility",
                "description": [
                    "No studies on the effects of ranibizumab on fertility have been conducted and it is not known whether ranibizumab can affect reproduction capacity",
                    "Based on mechanism of action, treatment may pose a risk to reproductive capacity"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data are available on drug presence in human milk, its effects on breastfed infants, or its effects on milk production/excretion",
            "Use drug with caution when administering to nursing females"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Endophthalmitis",
                    "description": [
                        "Implant associated with 3-fold higher rate of endophthalmitis than monthly intravitreal injections ",
                        "Many of these events were associated with conjunctival retractions or erosions ",
                        "Appropriate conjunctiva management and early detection with surgical repair of conjunctival retractions or erosions may reduce the risk of endophthalmitis"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "Ocular or periocular infections",
                "Active intraocular inflammation",
                "Hypersensitivity to ranibizumab or product excipients "
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Rhegmatogenous retinal detachments (eg, pneumatic retinopexy, vitrectomy, or laser photocoagulation) occurred and may result in vision loss; if this occurs, delay refill-exchange if retinal detachment or retinal break is present; carefully evaluate retinal periphery and treat any suspected areas of abnormal vitreoretinal adhesion or retinal breaks before inserting the implant ",
                "In clinical trials, the device has dislocated/subluxated into the vitreous cavity or has extended outside the vitreous cavity into or beyond the subconjunctival space; device dislocation requires urgent surgical intervention ",
                "Conjunctival erosions or retractions have been associated with increased risk of endophthalmitis; especially when implant is exposed; perform surgical intervention (eg, conjunctival/Tenon’s capsule repair) is recommended if conjunctival erosion or retraction with or without exposure of the implant flange is present",
                "Conjunctival blebs may require surgical management to avoid further complications, especially if implant septum is no longer identifiable due to the conjunctival bleb",
                "Visual acuity was decreased by 4 letters on average in the first postoperative month and 2 letters on average in the second postoperative month following initial implantation ",
                "Use caution when performing ophthalmic procedures (eg, B-scan ophthalmic ultrasound, scleral depression, gonioscopy) that may cause deflection of the implant and subsequent injury "
            ],
            "specific": [
                {
                    "type": "Endophthalmitis",
                    "description": [
                        "Risk of endophthalmitis or retinal detachment with intravitreous injections; cases more prevalent in intravitreal implant ",
                        "Always use proper aseptic injection technique when administering therapy",
                        "Monitor and treat promptly to reduce the risk of vision loss and maximize recovery",
                        "Patients should not have an active or suspected ocular or periocular infection or severe systemic infection at the time of any implant or refill procedure",
                        "Appropriate intraoperative handling followed by secure closure of the conjunctiva and Tenon’s capsule, and early detection and surgical repair of conjunctival erosions or retractions may reduce the risk of endophthalmitis"
                    ]
                },
                {
                    "type": "Air bubbles in implant reservoir ",
                    "description": [
                        "Minimize air bubbles within implant reservoir as they may cause slower drug release ",
                        "During initial fill procedure, if an air bubble is present, it must be ≤1/3 of the widest diameter of the implant; if excess air is observed after initial fill, do not use the implant",
                        "During refill-exchange procedure, if excess air is present in the syringe and needle do not use the syringe and needle; if excess air bubbles are observed after the refill-exchange procedure, consider repeating the refill-exchange procedure."
                    ]
                },
                {
                    "type": "Vitreous hemorrhages",
                    "description": [
                        "Vitreous hemorrhages may result in temporary vision loss; vitrectomy may be needed in the case of a non-clearing vitreous hemorrhage",
                        "Patients on antithrombotic medication (eg, oral anticoagulants, aspirin, nonsteroidal anti-inflammatory drugs) may be at increased risk of vitreous hemorrhage; temporarily hold antithrombotic medications before implant insertion",
                        "Delay dose (refill-exchange) in the event of sight-threatening vitreous hemorrhage",
                        "Use of pars plana laser ablation and perform scleral cauterization to reduce the risk of vitreous hemorrhage"
                    ]
                },
                {
                    "type": "Septum dislodgement",
                    "description": [
                        "Appropriate handling and insertion of refill needle into septum (avoid twisting and/or rotation) required to minimize risk of septum dislodgement",
                        "Implant damage where the septum has dislodged into implant body reported",
                        "Perform a dilated slit lamp exam and/or dilated indirect ophthalmoscopy to inspect the implant in vitreous cavity through the pupil before and after refill-exchange procedure to identify if septum dislodgement has occurred",
                        "Discontinue treatment following septum dislodgement and consider implant removal should benefit outweigh the risk"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Conjunctival hemorrhage",
            "percent": "72"
        },
        {
            "name": "Conjunctival hyperemia",
            "percent": "26"
        },
        {
            "name": "Iritis",
            "percent": "23"
        },
        {
            "name": "Eye pain",
            "percent": "10"
        },
        {
            "name": "Vitreous floaters",
            "percent": "9"
        },
        {
            "name": "Conjunctival bleb",
            "percent": "9"
        },
        {
            "name": "filtering bleb leak",
            "percent": "7"
        },
        {
            "name": "Foreign body sensation in eyes",
            "percent": "7"
        },
        {
            "name": "Headache",
            "percent": "6"
        },
        {
            "name": "Hypotony of eye",
            "percent": "6"
        },
        {
            "name": "Vitreous detachment",
            "percent": "5"
        },
        {
            "name": "Vitreous hemorrhage",
            "percent": "5"
        },
        {
            "name": "Conjunctival edema",
            "percent": "4"
        },
        {
            "name": "Corneal disorder",
            "percent": "4"
        },
        {
            "name": "Corneal abrasion",
            "percent": "4"
        },
        {
            "name": "Corneal edema",
            "percent": null
        }
    ]
}